The developer says removing the trees is 'essential' to its scheme in Wellingborough.
More than 50 lime trees were approved to be cut down to make way for a dual carriageway as part of the Stanton Cross development in Wellingborough
More than 50 lime trees were approved to be cut down to make way for a dual carriageway as part of the Stanton Cross development in Wellingborough.An exhibition was held on Thursday night to allow people to see and discuss the plans with developers.Developers and the council have previously said they would try to fell as few trees as possible
But following a public outcry, the work - which has been approved by North Northamptonshire Council - has been paused to allow discussions to take place.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
City Council says feedback on food waste trial ‘very positive’Thousands of homes have been involved
Read more »
Man yelled 'send me the bill' as he dumped his waste outside recycling centreCraig Davenport was captured on CCTV
Read more »
Nottingham food waste collection trial response 'positive'The council says it wants to boost all recycling rates without increasing the overall cost.
Read more »
Nottingham food waste collection trial response 'positive'The council says it wants to boost all recycling rates without increasing the overall cost.
Read more »
Braintree fly-tipping suspects caught on camera dumping rubbishA former police officer who took the photos warned 'we will get absolutely annihilated with rubbish' due to trade waste disposal regulations
Read more »
Institutional dashboards on clinical trial transparency for University Medical Centers: A case studyAuthor summary Why was this study done? Clinical trials are the foundation of evidence-based medicine and should follow established guidelines for transparency: Their results should be available, findable, and accessible regardless of the outcome. Previous studies have shown that many clinical trials fall short of transparency guidelines, which distorts the medical evidence base, creates research waste, and undermines medical decision-making. University Medical Centers (UMCs) play an important role in increasing clinical trial transparency but are often unaware of their performance on these practices, making it difficult to drive improvement. What did the researchers do and find? We developed a pipeline to evaluate clinical trials across several established practices for clinical trial transparency and applied it in a cohort of 2,895 clinical trials led by German UMCs. We found that while some practices are gaining adherence (e.g., prospective registration in ClinicalTrials.gov increased from 33% to 75% over the period considered), there is much room for improvement (e.g., 41% of trials reported results within 2 years of trial completion). We developed a dashboard to communicate these transparency assessments to UMCs and support their efforts to improve. What do these findings mean? Our study demonstrates the feasibility of developing a dashboard to communicate adherence to established practices for clinical trial transparency. By highlighting areas for improvement, the dashboard provides actionable information to UMCs and empowers their efforts to improve. The dashboard may inform interventions to increase clinical trial transparency and be scaled to other countries and stakeholders, such as funders or clinical trial registries.
Read more »